171 results
Page 4 of 9
8-K
EX-10.1
y7559hs9a6k
16 Dec 20
Departure of Directors or Certain Officers
5:01pm
8-K
EX-99.1
y6wg5d4v
20 Nov 20
Regulation FD Disclosure
7:36am
S-3ASR
EX-23.1
ojo70 rier0
10 Aug 20
Automatic shelf registration
5:01pm
S-3ASR
8ivceynuf
10 Aug 20
Automatic shelf registration
5:01pm
S-3ASR
EX-1.2
4hl5h4l ry6h085sh
10 Aug 20
Automatic shelf registration
5:01pm
424B5
lolmp h9mmm
2 Jun 20
Prospectus supplement for primary offering
5:05pm
8-K
EX-1.1
ihxv8
2 Jun 20
Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares
4:49pm
424B5
i87k96 6mwa401bf
1 Jun 20
Prospectus supplement for primary offering
6:06am
8-K
EX-99.1
e89gpsrppnww77y4
14 May 20
Adaptimmune Reports Q1 Financial Results
7:37am
8-K
EX-99.1
lzud 6aog0
27 Feb 20
Adaptimmune Reports Fourth Quarter / Full Year 2019 Financial Results and Business Update
7:39am
8-K
EX-10.1
vep9qk4 a4srmth6mxj2
18 Feb 20
Adaptimmune Announces Appointment of Gavin Wood as Chief Financial Officer
8:07am